Home › Second Circuit Affirms Preliminary Injunction in People of the State of New York v. Actavis PLC
 

Keywords :   


Second Circuit Affirms Preliminary Injunction in People of the State of New York v. Actavis PLC

2015-06-02 23:30:41| Biotech - Topix.net

We've previously covered the New York State Attorney General's lawsuit against Actavis PLC and Forest Laboratories seeking to prevent them from discontinuing sales of the Forest drug Namenda IR, which is used to treat Alzheimer's disease. New York has alleged that Actavis and Forest are engaging in "product hopping" - attempting to force prescribers and patients to switch to a new extended-release version of Namenda before a generic version can be launched.

Tags: v people state york

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05IT Cosmetics and Kenvue Launch New Products
19.05Virgin Trains targets West Coast in return to rail
19.05Cashing In On The Stache
19.05 Dr. Squatch Launches Bronco Bricc
19.05Gillette Venus Announces Ambassadors Ahead of the Olympic and Paralympic Games Paris 2024
19.05Eastern North Pacific Tropical Weather Outlook
More »